[1-(4-bromophenyl)cyclopropyl]methanamine
98%
- Product Code: 114570
CAS:
771583-34-7
Molecular Weight: | 226.11 g./mol | Molecular Formula: | C₁₀H₁₂BrN |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | 2-8°C, sealed, dry |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate in the synthesis of various biologically active molecules, particularly those targeting neurological and psychiatric disorders. Its structure, featuring a cyclopropyl group and a bromophenyl moiety, makes it valuable for designing compounds that interact with specific receptors or enzymes in the brain. Researchers often explore its derivatives for potential applications in developing antidepressants, anxiolytics, or other central nervous system (CNS) therapies. Additionally, its unique chemical framework is leveraged in the creation of novel compounds for studying structure-activity relationships (SAR) in drug discovery pipelines.
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
0.100 | 10-20 days | ฿3,078.00 |
+
-
|
0.250 | 10-20 days | ฿4,608.00 |
+
-
|
1.000 | 10-20 days | ฿11,520.00 |
+
-
|
[1-(4-bromophenyl)cyclopropyl]methanamine
This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate in the synthesis of various biologically active molecules, particularly those targeting neurological and psychiatric disorders. Its structure, featuring a cyclopropyl group and a bromophenyl moiety, makes it valuable for designing compounds that interact with specific receptors or enzymes in the brain. Researchers often explore its derivatives for potential applications in developing antidepressants, anxiolytics, or other central nervous system (CNS) therapies. Additionally, its unique chemical framework is leveraged in the creation of novel compounds for studying structure-activity relationships (SAR) in drug discovery pipelines.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :